webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate

  CAS No.: 64191-06-6   Cat No.: BADC-01546   Purity: 95% 4.5  

2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate is a linker widely used in antibody-drug conjugates (ADCs).

2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate

Structure of 64191-06-6

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C15H10N2O6
Molecular Weight
314.25

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
4-N-Maleimidobenzoicacid-NHS
IUPAC Name
(2,5-dioxopyrrolidin-1-yl) 4-(2,5-dioxopyrrol-1-yl)benzoate
Canonical SMILES
C1CC(=O)N(C1=O)OC(=O)C2=CC=C(C=C2)N3C(=O)C=CC3=O
InChI
InChI=1S/C15H10N2O6/c18-11-5-6-12(19)16(11)10-3-1-9(2-4-10)15(22)23-17-13(20)7-8-14(17)21/h1-6H,7-8H2
InChIKey
GSYZMVGSEGJHGT-UHFFFAOYSA-N
Pictograms
Harmful
Signal Word
Warning

2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate is extensively used in the field of bioconjugation techniques. This compound acts as an effective crosslinker that facilitates the linkage of biomolecules such as peptides, proteins, and nucleic acids. The ester component in its structure reacts with primary amines present in these biomolecules, forming stable amide bonds. This characteristic is crucial for creating conjugates that are utilized in diagnostic assays, targeted drug delivery systems, and molecular imaging. The robustness and specificity of the conjugation reaction make it a valuable tool in the development of advanced biotechnological applications.

Another significant application of 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate is in the synthesis of pharmaceutical intermediates. This compound serves as a key starting material in the synthesis of various bioactive molecules, particularly those used in anti-inflammatory and anticancer therapies. Its ability to form highly reactive intermediates allows for the introduction of specific functional groups necessary for the pharmacological activity of the final drug molecules. By leveraging this compound in synthetic pathways, pharmaceutical chemists can enhance the efficiency and yield of the drug development process, thereby accelerating the production of new therapeutic agents.

The compound is also employed in surface modification techniques, particularly for enhancing the biocompatibility and functionality of biomedical implants and devices. By grafting 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate onto the surfaces of materials such as metals, polymers, and ceramics, researchers can introduce functional groups that improve cell adhesion, protein binding, and antimicrobial properties. This surface modification is essential for the development of advanced medical devices like stents, catheters, and biosensors, ensuring they perform effectively in clinical settings and promote patient healing and recovery.

In the realm of polymer chemistry, 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate is utilized as a monomer for creating specialized functional polymers. These polymers exhibit unique properties, such as enhanced mechanical strength, thermal stability, and chemical resistance, which are advantageous for various industrial applications. For instance, functional polymers synthesized from this compound are used in the production of high-performance coatings, adhesives, and resins. Additionally, these polymers are explored in the development of smart materials with responsive behaviors to environmental stimuli, opening up new possibilities in material science and engineering.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: PPA | RapaLink-1 | 1,14-Dichloro-3,6,9,12-tetraoxatetradecane | (S)-2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate | 13-Iodo-2,5,8,11-tetraoxatridecane | 23-Hydroxy-3,6,9,12,15,18,21-heptaoxatricosyl 4-methylbenzenesulfonate | 3-Oxo-1-phenyl-2,7,10,13,16-pentaoxa-4-azaoctadecan-18-oic acid | O-(2-(2-(2-(Prop-2-yn-1-yloxy)ethoxy)ethoxy)ethyl)hydroxylamine | 3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol | N-(35-amino-3,6,9,12,15,18,21,24,27,30,33-undecaoxapentatriacontyl)-4-formylbenzamide | 2,5-Dioxopyrrolidin-1-yl 4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoate
Send Inquiry
Verification code
Inquiry Basket